


CYTACOAT ANNOUNCES APPOINTMENT OF GRAEME BROOKES AS CEO
CytaCoat announces appointment of Graeme Brookes as CEO June 22, 2021 CytaCoat AB, developers of the unique CytaCoat anti-microbial coating technology, have appointed Graeme Brookes as Chief Executive Officer. Graeme’s appointment further strengthens the...
CytaCoat coating inactivates SARS-CoV-2 (COVID-19)
CytaCoat coating inactivates SARS-CoV-2 (COVID-19) Press release Stockholm, July 9, 2020 The study was performed by the University of Tennessee Health Science Center (UTHSC) Regional Bioconception Laboratory, in May 2020. Silicone with and without CytaCoat...
CytaCoat publishes an article in Material Science & Engineering C…
Material Science & Engineering C publication A novel cysteine-linked antibacterial surface coating significantly inhibits bacterial colonization of nasal silicone prongs in a phase one pre-clinical trial Ventilator associated pneumonia and sepsis are...
CytaCoat awarded a Seal of Excellence in EIC Accelerator
Project name: CYTAMED “The project “A universal life-saving protection for medical devices – a new tool for reduction of hospital infections in the global battle against antibiotic resistance”, proposal 946737, was awarded a “Seal of Excellence” in November...